This announcement is a separate document:
科源制药：德恒上海律师事务所关于山东科源制药股份有限公司2023年年度股东大会之见证意见
Keyuan Pharmaceutical: Deheng Shanghai Law Firm's Testimony on the 2023 Annual General Meeting of Shareholders of Shandong Keyuan Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.